Mycio Wealth Partners, LLC Tg Therapeutics, Inc. Transaction History

Mycio Wealth Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $502,299 - $1.12 Million	-70,350 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$4.02 - $8.04 $101,906 - $203,813	25,350 Added 56.33%	70,350 $566,000
Q4 2018 Jan 22, 2019	SELL	$3.44 - $5.76 $86,688 - $145,152	-25,200 Reduced 35.9%	45,000 $185,000
Q2 2018 Jul 19, 2018	BUY	$12.5 - $15.0 $877,500 - $1.05 Million	70,200 New	70,200 $923,000

269

87.7M

2.72M

1.74M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $2.84B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mycio Wealth Partners, LLC with notifications on news.